Table 1,
Baseline Characteristics, Overall and by Race/Ethnicity
| Total | Black | Chinese | Japanese | Hispanic | White | P-value | ||
|---|---|---|---|---|---|---|---|---|
| N (%) | 2514 (100) | 704 (28.0) | 214 (8.5) | 244 (9.7) | 136 (5.4) | 1216 (48.4) | ||
| Site, N (%) | ||||||||
| Southeast Michigan | 424 (16.4) | 256 (35.5) | 168 (13.5) | |||||
| Boston | 385 (14.9) | 166 (23.0) | 219 (17.6) | |||||
| Chicago | 343 (13.3) | 177 (24.5) | 166 (13.3) | |||||
| Oakland Area | 379 (14.7) | 214 (100) | 165 (13.2) | |||||
| Los Angeles | 440 (17.1) | 246 (100) | 194 (15.6) | |||||
| Newark | 233 (9.0) | 152 (100) | 81 (6.5) | |||||
| Pittsburgh | 376 (14.6) | 123 (17.0) | 253 (20.3) | |||||
| Age, mean (SD) | 53.3 (3.3) | 52.9 (3.1) | 52.9 (2.8) | 53.2 (2.8) | 56.5 (5.0) | 53.2 (3.3) | <0.001 | |
| Education, N (%) | ||||||||
| ≤high school | 548 (21.8) | 185 (26.3) | 61 (28.5) | 39 (16.0) | 89 (65.4) | 174 (14.3) | <0.001 | |
| Some college | 819 (32.6) | 287 (40.8) | 46 (21.5) | 89 (36.5) | 30 (22.1) | 367 (30.2) | ||
| College/grad degree | 1128 (44.9) | 233 (31.7) | 107 (50.0) | 116 (47.5) | 13 (9.6) | 669 (55.0) | ||
| missing | 19 (0.8) | 9 (1.3) | 0 (0.0) | 0 (0.0) | 4 (2.9) | 6 (0.5) | ||
| Financial straina, N (%) | 744 (29.6) | 284 (40.3) | 39 (18.2) | 66 (27.0) | 111 (81.6) | 244 (20.1) | <0.001 | |
| Medical burdenb | 1474 (58.6) | 518 (73.6) | 80 (37.4) | 92 (37.7) | 114 (83.8) | 670 (55.1) | <0.001 | |
| Menopausal status, N (%) | <0.001 | |||||||
| BSOc, no HTd use | 54 (2.1) | 27 (3.8) | 3 (1.4) | 1 (0.4) | 4 (2.9) | 19 (1.6) | ||
| BSO & HT use | 66 (2.6) | 19 (2.7) | 5 (2.3) | 7 (2.9) | 1 (0.7) | 34 (2.8) | ||
| Post menopause, no HT | 926 (36.8) | 277 (39.3) | 81 (37.9) | 84 (34.4) | 90 (66.2) | 394 (32.4) | ||
| Post menopause & HT use | 249 (9.9) | 49 (7.0) | 14 (6.5) | 25 (10.2) | 2 (1.5) | 159 (13.1) | ||
| Late Peri-menopause | 248 (9.9) | 72 (10.2) | 22 (10.3) | 26 (10.7) | 11 (8.1) | 117 (9.6) | ||
| Early Peri-menopause | 653 (26.0) | 187 (26.6) | 62 (29.0) | 75 (30.7) | 20 (14.7) | 309 (25.4) | ||
| Pre-menopause | 57 (2.3) | 18 (2.6) | 6 (2.8) | 5 (2.0) | 0 (0.0) | 28 (2.3) | ||
| Undetermined due to HT | 198 (7.9) | 23 (3.3) | 21 (9.8) | 17 (7.0) | 3 (2.2) | 134 (11.0) | ||
| Undetermined due to Hysterectomy | 63 (2.5) | 32 (4.5) | 0 (0.0) | 4 (1.6) | 5 (3.7) | 22 (1.8) | ||
| Number of Menopausal Symptomsc, N (%) | <0.001 | |||||||
| 0 | 639 (25.4) | 128 (18.2) | 60 (28.0) | 78 (32.0) | 34 (25.0) | 339 (27.9) | ||
| 1 | 775 (30.8) | 181 (25.7) | 84 (39.3) | 85 (34.8) | 48 (35.3) | 377 (3.0) | ||
| 2 | 694 (27.6) | 257 (36.5) | 43 (20.1) | 48 (19.7) | 26 (19.1) | 320 (26.3) | ||
| 3 | 406 (16.1) | 138 (19.6) | 27 (12.6) | 33 (13.5) | 28 (20.6) | 180 (14.8) | ||
| Night sweats, N (%) | <0.001 | |||||||
| None | 1387 (55.3) | 305 (43.4) | 148 (69.5) | 162 (66.4) | 78 (57.4) | 694 (57.3) | ||
| 1-5 days | 733 (29.2) | 263 (37.4) | 49 (23.0) | 57 (23.4) | 35 (25.7) | 329 (27.1) | ||
| 6-8 days | 140 (5.6) | 50 (7.1) | 2 (0.9) | 7 (2.9) | 10 (7.4) | 71 (5.9) | ||
| 9-13 days | 82 (3.3) | 21 (3.0) | 6 (2.8) | 4 (1.6) | 3 (2.2) | 48 (4.0) | ||
| Every day | 166 (6.6) | 64 (9.1) | 8 (3.8) | 14 (5.7) | 10 (7.4) | 70 (5.8) | ||
| Hot flashes, N (%) | <0.001 | |||||||
| None | 1130 (45.1) | 217 (30.9) | 110 (51.9) | 127 (52.0) | 87 (64.0) | 589 (48.6) | ||
| 1-5 days | 771 (30.8) | 261 (37.2) | 68 (32.1) | 67 (27.5) | 22 (16.2) | 353 (29.1) | ||
| 6-8 days | 190 (7.6) | 68 (9.7) | 17 (8.0) | 14 (5.7) | 10 (7.4) | 81 (6.7) | ||
| 9-13 days | 145 (5.8) | 50 (7.1) | 5 (2.4) | 16 (6.6) | 5 (3.7) | 69 (5.7) | ||
| Every day | 271 (10.8) | 106 (15.1) | 12 (5.7) | 20 (8.2) | 12 (8.8) | 121 (10.0) | ||
| Vaginal dryness, N (%) | <0.001 | |||||||
| None | 1619 (64.7) | 476 (67.8) | 125 (59.8) | 163 (66.8) | 59 (43.4) | 796 (65.7) | ||
| 1-5 days | 504 (20.1) | 147 (20.9) | 38 (18.2) | 50 (20.5) | 44 (32.4) | 225 (18.6) | ||
| 6-8 days | 120 (4.8) | 23 (3.3) | 15 (7.2) | 12 (4.9) | 15 (11.0) | 55 (4.5) | ||
| 9-13 days | 72 (2.9) | 19 (2.7) | 6 (2.9) | 3 (1.2) | 7 (5.1) | 37 (3.1) | ||
| Every day | 187 (7.5) | 37 (5.3) | 25 (12.0) | 16 (6.6) | 11 (8.1) | 98 (8.1) | ||
| CAM/HT use, N (%) | <0.001 | |||||||
| Neither | 1628 (64.8) | 501 (71.2) | 142 (66.4) | 149 (61.1) | 125 (91.9) | 711 (58.5) | ||
| CAM only | 361 (14.4) | 108 (15.3) | 32 (15.0) | 45 (18.4) | 5 (3.7) | 171 (14.1) | ||
| HT only | 422 (16.8) | 76 (10.8) | 30 (14.0) | 39 (16.0) | 5 (3.7) | 272 (22.4) | ||
| Both | 103 (4.1) | 19 (2.7) | 10 (4.7) | 11 (4.5) | 1 (0.7) | 62 (5.1) | ||
| Self-reported QoL, mean (SD) | 7.4 (1.7) | 7.3 (1.8) | 7.2 (1.5) | 7.4 (1.7) | 7.5 (2.0) | 7.6 (1.6) | <0.001 | |
| SF36 Physical Component, mean (SD) | 50.2 (9.4) | 47.7 (10.7) | 50.5 (7.7) | 52.2 (6.4) | 49.6 (9.3) | 51.3 (9.1) | <0.001 | |
| SF36 Mental Component, mean (SD) | 50.0 (10.0) | 50.0 (10.2) | 49.6 (10.0) | 51.0 (9.0) | 47.1 (10.5) | 50.2 (9.9) | 0.005 |
BSO: Bilateral Salpingo-oophorectomy; CAM: Complementary Alternative Medicine use for menopausal symptom relief; HT: Hormone Therapy; QoL: Quality of Life: SF36: Short Form-36.
a
Financial strain: table entry shows number (percent) endorsing ‘very hard’ or ‘somewhat hard’ to pay for basics versus ‘not hard at all.
b
Medical burden: 2 or more medical conditions. Medical conditions include: diabetes, cardiovascular disease, hypertension, arthritis, hypercholesterolemia, stroke, anemia, migraines, angina, osteoporosis
c
Number of symptoms reported in the previous 2 weeks